Login to Your Account



Search

Search results

Clinic Roundup

No Abstract (BioWorld Today, BioWorld-Today-2006-06-29) ...

BioWorld Today - Staff - 2006-06-29 00:00 - 0 comments - 0 attachments

Clinic Roundup

No Abstract (BioWorld Today, BioWorld-Today-2010-08-06) ...

BioWorld Today - Staff - 2010-08-06 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Avillion Group , of London, said it entered an exclusive collaborative development agreement with Pfizer Inc. , of New York, to conduct a Phase III trial of Bosulif (bosutinib). (BioWorld-Today-2014-01-10) ...

BioWorld Today - Staff - 2014-01-10 01:00 - 0 comments - 0 attachments

Clinic Roundup

No Abstract (BioWorld Today, BioWorld-Today-2009-06-30) ...

BioWorld Today - Staff - 2009-06-30 00:00 - 0 comments - 0 attachments

Clinic Roundup

No Abstract (BioWorld Today, BioWorld-Today-2008-12-05) ...

BioWorld Today - Staff - 2008-12-05 01:00 - 0 comments - 0 attachments

Clinic Roundup

No Abstract (BioWorld Today, BioWorld-Today-2006-03-15) ...

BioWorld Today - Staff - 2006-03-15 01:00 - 0 comments - 0 attachments

Clinic Roundup

No Abstract (BioWorld Today, BioWorld-Today-2006-05-02) ...

BioWorld Today - Staff - 2006-05-02 00:00 - 0 comments - 0 attachments

Clinic roundup

Brainstorm Cell Therapeutics Inc. , of New York and Petach Tikvah, Israel, said the FDA approved commencement of its phase II trial with Nurown in patients with amyotrophic lateral sclerosis (ALS). (BioWorld-Today-2014-04-29) ...

BioWorld Today - Staff - 2014-04-29 00:00 - 0 comments - 0 attachments

Clinic Roundup

Threshold Pharmaceuticals Inc., of Redwood City, Calif., initiated a clinical trial of TH-302 in combination with bevacizumab (Avastin, Roche AG) in patients with recurrent high-grade astrocytoma including glioblastoma. TH-302 is a novel small-molecule ...

BioWorld Today - Staff - 2011-07-26 00:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Astellas Pharma US Inc ., of Northbrook, Ill., part of Astellas Pharma Inc., reported that efficacy and safety data of the isavuconazole invasive aspergillosis study (SECURE) were presented at the European Congress of Clinical Microbiology and Infect ...

BioWorld Today - Staff - 2014-05-15 00:00 - 0 comments - 0 attachments